125 related articles for article (PubMed ID: 18307534)
1. Novel BRCA2-interacting protein BJ-HCC-20A inhibits the induction of apoptosis in response to DNA damage.
Tomiyoshi G; Nakanishi A; Takenaka K; Yoshida K; Miki Y
Cancer Sci; 2008 Apr; 99(4):747-54. PubMed ID: 18307534
[TBL] [Abstract][Full Text] [Related]
2. M phase-specific phosphorylation of BRCA2 by Polo-like kinase 1 correlates with the dissociation of the BRCA2-P/CAF complex.
Lin HR; Ting NS; Qin J; Lee WH
J Biol Chem; 2003 Sep; 278(38):35979-87. PubMed ID: 12815053
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of BRCA2 by the Polo-like kinase Plk1 is regulated by DNA damage and mitotic progression.
Lee M; Daniels MJ; Venkitaraman AR
Oncogene; 2004 Jan; 23(4):865-72. PubMed ID: 14647413
[TBL] [Abstract][Full Text] [Related]
4. Intrinsic Disorder and Phosphorylation in BRCA2 Facilitate Tight Regulation of Multiple Conserved Binding Events.
Julien M; Ghouil R; Petitalot A; Caputo SM; Carreira A; Zinn-Justin S
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356684
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of BRCA1 and BRCA2 in human ovarian cancer cells exposed to adriamycin and ultraviolet radiation.
Fan S; Twu NF; Wang JA; Yuan RQ; Andres J; Goldberg ID; Rosen EM
Int J Cancer; 1998 Aug; 77(4):600-9. PubMed ID: 9679765
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis.
Yang XM; Cao XY; He P; Li J; Feng MX; Zhang YL; Zhang XL; Wang YH; Yang Q; Zhu L; Nie HZ; Jiang SH; Tian GA; Zhang XX; Liu Q; Ji J; Zhu X; Xia Q; Zhang ZG
Gastroenterology; 2018 Oct; 155(4):1233-1249.e22. PubMed ID: 30009820
[TBL] [Abstract][Full Text] [Related]
7. Polo-like kinase 1 is essential to DNA damage recovery.
Liu L; Zhang M; Zou P
Leuk Lymphoma; 2010 Jun; 51(6):1079-89. PubMed ID: 20470222
[TBL] [Abstract][Full Text] [Related]
8. Runt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosis through the collaboration with HDAC6 in response to DNA damage.
Ozaki T; Wu D; Sugimoto H; Nagase H; Nakagawara A
Cell Death Dis; 2013 Apr; 4(4):e610. PubMed ID: 23618908
[TBL] [Abstract][Full Text] [Related]
9. [Recent advances in PLK1 and breast cancer].
Liu ZY; Niu Y; Zhang RJ
Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):427-9. PubMed ID: 21914359
[No Abstract] [Full Text] [Related]
10. Up-regulation of pro-apoptotic protein Bim and down-regulation of anti-apoptotic protein Mcl-1 cooperatively mediate enhanced tumor cell death induced by the combination of ERK kinase (MEK) inhibitor and microtubule inhibitor.
Kawabata T; Tanimura S; Asai K; Kawasaki R; Matsumaru Y; Kohno M
J Biol Chem; 2012 Mar; 287(13):10289-10300. PubMed ID: 22270368
[TBL] [Abstract][Full Text] [Related]
11. Plk1 and CK2 act in concert to regulate Rad51 during DNA double strand break repair.
Yata K; Lloyd J; Maslen S; Bleuyard JY; Skehel M; Smerdon SJ; Esashi F
Mol Cell; 2012 Feb; 45(3):371-83. PubMed ID: 22325354
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow stromal cell-derived growth inhibitor inhibits growth and migration of breast cancer cells via induction of cell cycle arrest and apoptosis.
Wang T; Xia D; Li N; Wang C; Chen T; Wan T; Chen G; Cao X
J Biol Chem; 2005 Feb; 280(6):4374-82. PubMed ID: 15569677
[TBL] [Abstract][Full Text] [Related]
13. Proteins ZNF198 and SUZ12 are down-regulated in hepatitis B virus (HBV) X protein-mediated hepatocyte transformation and in HBV replication.
Wang WH; Studach LL; Andrisani OM
Hepatology; 2011 Apr; 53(4):1137-47. PubMed ID: 21480320
[TBL] [Abstract][Full Text] [Related]
14. Aurora kinase A promotes ovarian tumorigenesis through dysregulation of the cell cycle and suppression of BRCA2.
Yang G; Chang B; Yang F; Guo X; Cai KQ; Xiao XS; Wang H; Sen S; Hung MC; Mills GB; Chang S; Multani AS; Mercado-Uribe I; Liu J
Clin Cancer Res; 2010 Jun; 16(12):3171-81. PubMed ID: 20423983
[TBL] [Abstract][Full Text] [Related]
15. TSA suppresses miR-106b-93-25 cluster expression through downregulation of MYC and inhibits proliferation and induces apoptosis in human EMC.
Zhao ZN; Bai JX; Zhou Q; Yan B; Qin WW; Jia LT; Meng YL; Jin BQ; Yao LB; Wang T; Yang AG
PLoS One; 2012; 7(9):e45133. PubMed ID: 23028803
[TBL] [Abstract][Full Text] [Related]
16. Polo-like kinase-1 as a novel target in neoplastic mast cells: demonstration of growth-inhibitory effects of small interfering RNA and the Polo-like kinase-1 targeting drug BI 2536.
Peter B; Gleixner KV; Cerny-Reiterer S; Herrmann H; Winter V; Hadzijusufovic E; Ferenc V; Schuch K; Mirkina I; Horny HP; Pickl WF; Müllauer L; Willmann M; Valent P
Haematologica; 2011 May; 96(5):672-80. PubMed ID: 21242189
[TBL] [Abstract][Full Text] [Related]
17. Polo-like kinase 1 inhibits DNA damage response during mitosis.
Benada J; Burdová K; Lidak T; von Morgen P; Macurek L
Cell Cycle; 2015; 14(2):219-31. PubMed ID: 25607646
[TBL] [Abstract][Full Text] [Related]
18. Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents.
Andres JL; Fan S; Turkel GJ; Wang JA; Twu NF; Yuan RQ; Lamszus K; Goldberg ID; Rosen EM
Oncogene; 1998 Apr; 16(17):2229-41. PubMed ID: 9619832
[TBL] [Abstract][Full Text] [Related]
19. Genistein-induced neuronal apoptosis and G2/M cell cycle arrest is associated with MDC1 up-regulation and PLK1 down-regulation.
Ismail IA; Kang KS; Lee HA; Kim JW; Sohn YK
Eur J Pharmacol; 2007 Dec; 575(1-3):12-20. PubMed ID: 17706963
[TBL] [Abstract][Full Text] [Related]
20. Polo-like kinase 1 inhibition suppresses hepatitis B virus X protein-induced transformation in an in vitro model of liver cancer progression.
Studach LL; Rakotomalala L; Wang WH; Hullinger RL; Cairo S; Buendia MA; Andrisani OM
Hepatology; 2009 Aug; 50(2):414-23. PubMed ID: 19472310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
